AR and urinary bladder cancer: Shang et al. performed an intriguing study in the BBN-model, showing that the anti-tumor effect of bacille Calmette–Guérin (BCG, an immunotherapy frequently used in bladder cancer [39]) was augmented using multiple AR-targeting strategies, and it also increased bladder infiltration by F4/80+ macrophages [40].